NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.83−0.05 (-5.66%)
Close on Nov 20, 2026Market cap $95.77MP/E –Yield –
NovaBridge Biosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
NovaBridge Biosciences's free cash flow for the twelve months ending Dec 31, 2020 was CN¥425.55M. For fiscal 2023 it was -CN¥1.32B. The highest annual figure on record is CN¥425.55M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -CN¥1.32B | – |
| FY2022 | Dec 31, 2022 | -CN¥1.15B | – |
| FY2021 | Dec 31, 2021 | -CN¥1.00B | -335.7% |
| FY2020 | Dec 31, 2020 | CN¥425.55M | – |
| FY2019 | Dec 31, 2019 | -CN¥880.22M | – |
| FY2018 | Dec 31, 2018 | -CN¥295.11M | – |
| FY2017 | Dec 31, 2017 | -CN¥272.48M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | CN¥1.01B | – |
| Q4 FY2019 | Dec 31, 2019 | -CN¥223.61M | – |
See a number that looks wrong?